Dr Frida Bugge Askeland, associated research doctor and PhD student at the Oslo...
Dr Gabriel Brisou presents preliminary findings on the utilization of axi-cel...
KarMMa-3 constitutes an open-label, phase 3 randomized clinical trial aimed at...
Dr Rutger Callens, a haematologist at AZ Delta in Roeselare, delved into the...
Two investigations provide novel insights into optimizing the therapeutic...
BTKi has demonstrated efficacy in MCL; however, a substantial number of...
Dr Cecilie Blimark, haematologist at the Sahlgrenska University Hospital in...
Dr Margo Aertgeerts from UZ Leuven presented her PhD research in ALL, the most...
T-ALL represents a highly aggressive haematological malignancy, characterized...
Dr Annemiek Broijl, haematologist at the Erasmus MC hospital in Rotterdam, the...